Kolexia
Rochaix Philippe
Anatomie et cytologie
Institut Universitaire du Cancer Toulouse Oncopole
Toulouse, France
93 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Sarcomes Tumeurs du sein Tumeurs de la tête et du cou Métastase tumorale Carcinomes Tumeurs cutanées Mélanome expérimental Métastases d'origine inconnue

Industries

MSD
12 collaboration(s)
Dernière en 2023
Roche
12 collaboration(s)
Dernière en 2022
A+A
2 collaboration(s)
Dernière en 2022
BMS
1 collaboration(s)
Dernière en 2022

Dernières activités

Impact de la TEP-TDM au 18F-FDG sur la prise en charge des sarcomes des tissus mous de l’adulte en situation initiale ou de récidive
10e Journées Francophones de Médecine nucléaire - Biarritz   01 mars 2024
Management of tumor volume changes during preoperative radiotherapy for extremity soft tissue sarcoma: a new strategy of adaptive radiotherapy.
Radiology and oncology   30 novembre 2023
137P VEGFR-3 expression profiling by histology and mRNA signature to classify patient population for the selective VEGFR-3 inhibitor EVT801
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Multicenter Harmonization Study of Pan-Trk Immunohistochemistry for the Detection of NTRK3 Fusions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   20 avril 2023
Abstract 1015: VEGFR-3 expression profiling by histology to classify patient population for the selective VEGFR-3 inhbitor EVT801
Proceedings: AACR Annual Meeting 2023   01 avril 2023
Distinct Cellular Origins and Differentiation Process Account for Distinct Oncogenic and Clinical Behaviors of Leiomyosarcomas.
Cancers   15 janvier 2023
Targeting Tumor Angiogenesis with the Selective VEGFR-3 Inhibitor EVT801 in Combination with Cancer Immunotherapy.
Cancer research communications   29 novembre 2022
EBUS-TBNA for the diagnosis of primary pulmonary artery sarcoma.
Respiratory medicine and research   17 novembre 2022
Medium levels of transcription and replication related chromosomal instability are associated with poor clinical outcome.
Scientific reports   06 décembre 2021
Exploratory window-of-opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer.
Clinical and translational science   11 novembre 2021